INR 749.5
(-0.43%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 17.28 Million INR | 90.11% |
2022 | 9.09 Million INR | 3.32% |
2021 | 8.79 Million INR | -34.45% |
2020 | 13.42 Million INR | -20.72% |
2019 | 16.93 Million INR | 0.0% |
2018 | - INR | 0.0% |
2017 | - INR | -100.0% |
2016 | 24.82 Million INR | -0.69% |
2015 | 25 Million INR | 0.0% |
2014 | 25 Million INR | -68.75% |
2013 | 80 Million INR | -46.87% |
2012 | 150.56 Million INR | 146.35% |
2011 | 61.11 Million INR | 65.3% |
2010 | 36.97 Million INR | 167.85% |
2009 | 13.8 Million INR | 320.45% |
2008 | 3.28 Million INR | -96.12% |
2007 | 84.67 Million INR | 10.16% |
2006 | 76.86 Million INR | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 Q3 | - INR | -100.0% |
2023 Q4 | 17.28 Million INR | 0.0% |
2023 FY | 17.28 Million INR | 90.11% |
2023 Q1 | - INR | -100.0% |
2023 Q2 | 6.65 Million INR | 0.0% |
2022 Q1 | - INR | -100.0% |
2022 Q3 | - INR | -100.0% |
2022 FY | 9.09 Million INR | 3.32% |
2022 Q4 | 9.09 Million INR | 0.0% |
2022 Q2 | 6.23 Million INR | 0.0% |
2021 Q1 | - INR | -100.0% |
2021 FY | 8.79 Million INR | -34.45% |
2021 Q2 | 10.21 Million INR | 0.0% |
2021 Q4 | 8.79 Million INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2020 FY | 13.42 Million INR | -20.72% |
2020 Q2 | 15.76 Million INR | 0.0% |
2020 Q4 | 13.42 Million INR | 0.0% |
2020 Q3 | - INR | -100.0% |
2020 Q1 | - INR | -100.0% |
2019 Q3 | - INR | -100.0% |
2019 Q4 | 16.93 Million INR | 0.0% |
2019 Q2 | 17.33 Million INR | 0.0% |
2019 Q1 | - INR | 0.0% |
2019 FY | 16.93 Million INR | 0.0% |
2018 Q1 | - INR | 0.0% |
2018 FY | - INR | 0.0% |
2018 Q4 | - INR | 0.0% |
2018 Q3 | - INR | 0.0% |
2018 Q2 | - INR | 0.0% |
2017 Q4 | - INR | 0.0% |
2017 Q1 | - INR | -100.0% |
2017 Q2 | - INR | 0.0% |
2017 FY | - INR | -100.0% |
2016 FY | 24.82 Million INR | -0.69% |
2016 Q4 | 24.82 Million INR | 0.0% |
2015 FY | 25 Million INR | 0.0% |
2014 FY | 25 Million INR | -68.75% |
2013 FY | 80 Million INR | -46.87% |
2012 FY | 150.56 Million INR | 146.35% |
2012 Q2 | 75 Million INR | 0.0% |
2012 Q4 | 150.56 Million INR | 0.0% |
2011 FY | 61.11 Million INR | 65.3% |
2010 FY | 36.97 Million INR | 167.85% |
2009 FY | 13.8 Million INR | 320.45% |
2008 FY | 3.28 Million INR | -96.12% |
2007 FY | 84.67 Million INR | 10.16% |
2006 FY | 76.86 Million INR | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Ajanta Pharma Limited | 352.8 Million INR | 95.101% |
Sigachi Industries Limited | 1.43 Billion INR | 98.792% |
Bal Pharma Limited | 1.39 Billion INR | 98.762% |
Ind-Swift Laboratories Limited | 166.21 Million INR | 89.602% |
Medico Remedies Limited | 80.5 Million INR | 78.532% |
Lasa Supergenerics Limited | 220.76 Million INR | 92.171% |
Venus Remedies Limited | 413.3 Million INR | 95.818% |
Sun Pharma Advanced Research Company Limited | 611.5 Million INR | 97.174% |
Alpa Laboratories Limited | 52.46 Million INR | 67.058% |
Nectar Lifesciences Limited | 6.35 Billion INR | 99.728% |
Shilpa Medicare Limited | 9.37 Billion INR | 99.816% |
Aarti Drugs Limited | 5.64 Billion INR | 99.694% |
Lupin Limited | 29.21 Billion INR | 99.941% |
Aurobindo Pharma Limited | 66.47 Billion INR | 99.974% |
Zydus Lifesciences Limited | 8.04 Billion INR | 99.785% |
Windlas Biotech Limited | 36.41 Million INR | 52.532% |
Suven Life Sciences Limited | 7.09 Million INR | -143.525% |
Eris Lifesciences Limited | 27.81 Billion INR | 99.938% |
Valiant Laboratories Limited | 767.08 Million INR | 97.747% |
J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | 99.542% |
Solara Active Pharma Sciences Limited | 10.11 Billion INR | 99.829% |
Ipca Laboratories Limited | 14.38 Billion INR | 99.88% |
Bliss GVS Pharma Limited | 998.4 Million INR | 98.269% |
Achyut Healthcare Limited | - INR | -Infinity% |
Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 99.947% |
Bajaj HealthCare Limited | 3.32 Billion INR | 99.481% |
RPG Life Sciences Limited | - INR | -Infinity% |
Mankind Pharma Limited | 2.07 Billion INR | 99.166% |
Laurus Labs Limited | 25.77 Billion INR | 99.933% |
Piramal Pharma Limited | 47.1 Billion INR | 99.963% |
Syncom Formulations (India) Limited | 724.86 Million INR | 97.616% |
Torrent Pharmaceuticals Limited | 40.22 Billion INR | 99.957% |
Alembic Pharmaceuticals Limited | 5.13 Billion INR | 99.663% |
Glenmark Pharmaceuticals Limited | 12.3 Billion INR | 99.86% |
Unichem Laboratories Limited | 2.47 Billion INR | 99.302% |
Sequent Scientific Limited | 4.87 Billion INR | 99.646% |
Novartis India Limited | 69.7 Million INR | 75.204% |
Wanbury Limited | 1.16 Billion INR | 98.516% |
Suven Pharmaceuticals Limited | 649.96 Million INR | 97.341% |
Wockhardt Limited | 23.56 Billion INR | 99.927% |
Themis Medicare Limited | 957.92 Million INR | 98.196% |
Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | 80.67% |
Jubilant Pharmova Limited | 36.64 Billion INR | 99.953% |
Glenmark Life Sciences Limited | 171.48 Million INR | 89.921% |
Dr. Reddy's Laboratories Limited | 20.02 Billion INR | 99.914% |
Divi's Laboratories Limited | 30 Million INR | 42.39% |
NATCO Pharma Limited | 3.71 Billion INR | 99.534% |
Gufic Biosciences Limited | 3.32 Billion INR | 99.481% |
IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | 94.724% |
Ind-Swift Limited | 10.13 Billion INR | 99.83% |
Procter & Gamble Health Limited | 95.6 Million INR | 81.922% |
FDC Limited | 205.18 Million INR | 91.577% |
Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 99.106% |
Granules India Limited | 13.15 Billion INR | 99.869% |
Medicamen Biotech Limited | 308.17 Million INR | 94.392% |
Alkem Laboratories Limited | 14.18 Billion INR | 99.878% |
AstraZeneca Pharma India Limited | 45.98 Million INR | 62.414% |
Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -293.78% |
Brooks Laboratories Limited | 56.41 Million INR | 69.367% |
Megasoft Limited | 1.47 Billion INR | 98.825% |
ZIM Laboratories Limited | 1.08 Billion INR | 98.412% |
Strides Pharma Science Limited | 25.16 Billion INR | 99.931% |
Neuland Laboratories Limited | 953.89 Million INR | 98.188% |
Morepen Laboratories Limited | 289.99 Million INR | 94.04% |
Hikal Limited | 8.17 Billion INR | 99.789% |
Indoco Remedies Limited | 6.71 Billion INR | 99.743% |
Aarti Pharmalabs Limited | 2.85 Billion INR | 99.394% |
Kilitch Drugs (India) Limited | 316.46 Million INR | 94.539% |
Mangalam Drugs & Organics Limited | 984.92 Million INR | 98.245% |
Hester Biosciences Limited | 2.44 Billion INR | 99.293% |